Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2014
10/28/2014US8871775 Compounds
10/28/2014US8871774 Inhibitors of influenza viruses replication
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871753 Macrocyclic compounds and their use as kinase inhibitors
10/28/2014US8871747 Urea and thiourea derivatives
10/23/2014US20140315932 Quinazolinone derivatives useful as vanilloid antagonists
10/23/2014US20140315887 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
10/23/2014US20140315878 Chemical compounds
10/23/2014US20140315783 Pyrimidine diol amides as sodium channel blockers
10/23/2014US20140314785 Compositions and methods for inhibition of the jak pathway
10/21/2014US8865900 Methyltetrazole sulfides and sulfones
10/21/2014US8865899 Chemical process for the synthesis of 4-(4-bromo-2-fluoroanilino)-6-methoxy-7-(1-methylpiperidin-4-ylmethoxy)quinazoline
10/21/2014US8865898 Nucleoside analog or salt thereof, oligonucleotide analog, gene expression inhibitor, and nucleic-acid probe for detecting gene
10/21/2014US8865731 Inhibitor of analgesic tolerance
10/21/2014US8865723 Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865709 Aminooxazole inhibitors of cyclin dependent kinases
10/21/2014US8865704 Wnt pathway antagonists
10/16/2014US20140309421 Processes and intermediates for producing azaindoles
10/16/2014US20140309224 TREATMENT OF DISEASES OR DISORDERS CAUSED BY INDUCED NFkB TRANSCRIPTIONAL ACTIVITY
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140309185 Inhibiting G Protein Coupled Receptor 6 Kinase Polypeptides
10/14/2014US8859770 Process for preparing [4,6-bis-dimethylamino-2-[4-(4-trifluoromethylbenzoylamino)benzyl]pyrimidin-5-yl]acetic acid
10/14/2014US8859769 Processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
10/14/2014US8859768 Heteroaryls and uses thereof
10/14/2014US8859767 Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
10/14/2014US8859766 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859591 Glucagon receptor modulators
10/14/2014US8859590 Inhibitors of BACE1 and methods for treating Alzheimer's disease
10/14/2014US8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2
10/14/2014US8859571 Quinazoline compounds
10/14/2014US8859570 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/14/2014US8859561 Pyrido[4,3-b]indoles and methods of use
10/14/2014US8859529 Compounds for the treatment of inflammatory disorders
10/14/2014US8859490 Peptide nucleic acid monomers and oligomers
10/14/2014US8859060 Protective film of polarizer, polarizer and liquid crystal display device
10/09/2014WO2014164678A1 Translocator protein imaging agents; methods of manufacture, and methods of use thereof
10/09/2014WO2014163161A1 Heterocyclic compound
10/09/2014WO2014162126A1 Urea derivatives useful as kinase inhibitors
10/09/2014WO2014162122A1 Kinase inhibitor
10/09/2014US20140303369 Crystalline Pharmaceutical
10/09/2014US20140303188 Substituted Cyclopenta Pyrimidine Bicyclic Compounds Having Antitmitotic And/Or Antitumor Activity And Methods Of Use Thereof
10/09/2014US20140303179 Compounds and Pharmaceutical Compositions for Treating Disorders Associated With the 5-HT1A and 5-HT2A Receptors
10/09/2014US20140303165 Heteroaryl compounds and uses thereof
10/09/2014US20140303156 Novel (6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as akt(pkb) phosphorylation inhibitors
10/09/2014US20140303154 2,4-pyridinediamine compounds and their uses
10/09/2014US20140303139 Pyrimidines as sodium channel blockers
10/09/2014US20140303112 Method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK)
10/09/2014US20140301979 Anti-arenaviral compounds
10/09/2014US20140301944 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
10/08/2014EP2786983A1 Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof
10/08/2014EP2785699A1 2-phenylaminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
10/08/2014EP2785445A1 Production of 18f- labelled compounds comprising hydrolytic deprotection step and solid phase extraction
10/07/2014US8853427 Neprilysin inhibitors
10/07/2014US8853398 Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound
10/07/2014US8853397 2,4-pyrimidinediamine compounds and their uses
10/07/2014US8853281 Cysteine protease inhibitors
10/07/2014US8853230 Inhibitors of JAK
10/07/2014US8853228 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
10/07/2014US8853225 9-[4-(3-chloro-2-fluoro-phenylamino)-7-methoxy-quinazoline-6-yloxy]-1,4-diaza-spiro[5.5] undecane-5-one dimaleate, use thereof as a medicament and method for the production thereof
10/07/2014US8853221 Compounds of estrogen-related receptor modulators and the uses thereof
10/07/2014US8853219 Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
10/07/2014US8853218 Compounds
10/07/2014US8853216 Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor
10/07/2014US8853199 Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
10/02/2014WO2014160521A1 Piperazine derivatives and their use as kit modulators
10/02/2014WO2014157216A1 Photoelectric conversion material, photoelectric transducer and method of using said transducer, light sensor, and imaging element
10/02/2014WO2014155304A1 Preparation of pyrimidine intermediates useful for the manufacture of macitentan
10/02/2014WO2014154857A1 Amine salts of pitavastatin and rosuvastatin
10/02/2014WO2014154856A1 Amine salts of pravastatin and rosuvastatin
10/02/2014US20140296271 Kinase inhibitor
10/02/2014US20140296258 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibiton
10/02/2014US20140296247 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/02/2014US20140296245 Benzenesulfonamide compounds and their use as therapeutic agents
10/02/2014US20140296240 Substituted aminopropionic derivatives as neprilysin inhibitors
10/02/2014US20140296233 Heteroaryl compounds and uses thereof
10/02/2014US20140296208 Kinase inhibitors
10/02/2014US20140294766 Anti-Infective Agents and Uses Thereof
09/2014
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846915 Process for the manufacture of rosuvastatin calcium using crystalline rosuvastatin ethyl ester
09/30/2014US8846914 Compositions to effect neuronal growth
09/30/2014US8846913 Neprilysin inhibitors
09/30/2014US8846912 Tartrate salts of quinazoline based EGFR inhibitors containing a zinc binding moiety
09/30/2014US8846908 Tricyclic carbamate JAK inhibitors
09/30/2014US8846738 Fungicide active substance combinations
09/30/2014US8846708 Salt of a pyrimidin derivative
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846704 Thiopyrimidine-based compounds and uses thereof
09/30/2014US8846702 Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators
09/30/2014US8846701 Pyrazolo-quinazolines
09/30/2014US8846699 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof
09/30/2014US8846691 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring
09/30/2014US8846690 Heterocyclic carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring
09/30/2014US8846689 Substituted pyrimidines for the treatment of diseases such as cancer
09/30/2014US8846681 Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
09/30/2014US8846670 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
09/30/2014US8846654 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
09/30/2014US8846643 Phosphonates with reduced toxicity for treatment of viral infections
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 427